RELIC TECHNOLOGIES LTD.

Relic Technologies Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of its 35th Annual General Meeting (AGM). The AGM is scheduled for August 13, 2026, and will be conducted via Video Conferencing/Other Audio-Visual Means. The report includes audited standalone and consolidated financial statements, Board's Report, Management Discussion and Analysis, and Auditor's Reports. Key appointments and resignations within the Board of Directors are also detailed, including the appointment of Mr. Karthik Iyer and Ms. Neha Thakore, and the resignation of Mr. Mukesh J. Desai. The company also announced the appointment of CS Anita Gupta as Company Secretary & Compliance Officer.

Relic Technologies Ltd has announced the closure of its trading window for the quarter ended June 2026. The window will be effective from July 01, 2026, in compliance with SEBI (Prohibition of Insider Trading Code) Regulations, 2015. Trading will resume 48 hours after the board meeting where the unaudited financial results for the quarter will be approved. The company has informed its directors, promoters, auditors, and designated employees about this closure.

Relic Technologies Ltd announced significant management changes effective June 13, 2026. Mr. Sachin Srivastava has been appointed as Whole Time Director and Chief Executive Officer, bringing nearly 25 years of experience in pharmaceutical sales and marketing. Concurrently, Mr. Karthik Iyer has resigned as Executive Director and a Director of the Company, citing personal and health reasons. These appointments and resignations are in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mr. Karthik Iyer has resigned as Executive Director of Relic Technologies Ltd, effective June 13, 2026. He will also cease to be a Director of the Company. The resignation is due to personal and health reasons. The company has filed this information in compliance with SEBI regulations.

Relic Technologies Ltd announced significant management changes, appointing Mr. Sachin Srivastava as Whole Time Director and Chief Executive Officer, effective June 13, 2026. Concurrently, Mr. Karthik Iyer has resigned as Executive Director, also effective June 13, 2026, citing personal and health reasons. Mr. Srivastava brings nearly 25 years of experience in pharmaceutical sales and marketing, with a strong background in brand management, strategy, and market expansion. This leadership transition is expected to bring fresh perspectives and drive future growth for the company.

Relic Technologies Ltd announced key management changes following its Board Meeting on June 13, 2026. Mr. Sachin Srivastava has been appointed as an Additional Director and subsequently as the Whole Time Director and Chief Executive Officer, bringing nearly 25 years of experience in pharmaceutical sales and marketing. The company also revised its Directors' Report and the Notice of Annual General Meeting to reflect these changes. Concurrently, Mr. Karthik Iyer has resigned as an Executive Director of the company. The board meeting was brief, lasting from 2:15 PM to 2:45 PM IST.

Relic Technologies Ltd. announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The Board of Directors approved the results at a meeting held on May 23, 2026, which commenced at 12:00 PM (IST) and concluded at 1:00 PM (IST). The results include an Independent Auditor's Report with an Unmodified Opinion from D. KOTHARY & CO., Chartered Accountants.

Relic Technologies Ltd confirms no deviation in the utilization of proceeds from its preferential issue for the quarter ended March 31, 2026. Equity Shares and Share Warrants were allotted on April 5, 2025, with Share Warrants converted into Equity Shares on December 13, 2025. Proceeds were utilized as per the objects stated in the EGM resolutions on March 18, 2025. The Audit Committee reviewed and confirmed the utilization with no deviations.

Relic Technologies Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, during its meeting held on May 23, 2026. The approval includes the Auditors' Report and declaration related to the Unmodified Opinion issued by the Statutory Auditors. The board meeting commenced at 12:00 PM (IST) and concluded at 1:00 PM (IST).

Relic Technologies Ltd has scheduled a Board of Directors meeting on May 23, 2026, to consider and approve the audited financial results (standalone and consolidated) for the fourth quarter and financial year ended March 31, 2026, along with the audit report for the corresponding period. The trading window for designated persons remains closed from April 01, 2026, until 48 hours after the results are declared.